Billable / Specific Code
ICD-10-CM G71.0342 is the diagnosis code for Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction. This code falls under the section "Diseases of myoneural junction and muscle" within Chapter 6 — Diseases of the nervous system (G00-G99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where G71.0342 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, G71.0342 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
G71.0342 is the ICD-10-CM diagnosis code for "Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of G71.0342 is G71.034 ("Limb girdle muscular dystrophy due to sarcoglycan dysfunction"). G71.0342 provides a more specific classification within this category.
G71.0342 is located in Section G70-G73 — "Diseases of myoneural junction and muscle" within Chapter 6 of the ICD-10-CM Tabular List.
Use G71.0342 when the patients documented diagnosis matches "Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction is G71.0342.
Yes, G71.0342 can be used as a primary diagnosis code since it is billable and specific.
G71.0342 is in Chapter 6 of the ICD-10-CM Tabular List.
Yes, G71.0342 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.